Johnson & Johnson (JNJ) Tops Q4 EPS by 2c, Offers FY Guidance

Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.97, $0.02 better than the analyst estimate of $1.95. Revenue for the quarter came in at $20.4 billion versus the consensus estimate of $20.17 billion.

GUIDANCE:

Johnson & Johnson sees FY2019 EPS of $8.50-$8.65, versus the consensus of $8.61. Johnson & Johnson sees FY2019 revenue of $80.4-81.2 billion, versus the consensus of $82.68 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Arrive AI and DXC Technology partner to bring delivery tech to factories
• UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'